Funder: European Commission
Due Dates: September 16, 2025 (Full proposal, single-stage)
Funding Amounts: €7–10 million per project | Total budget: €31 million | 4 grants expected
Summary: Supports validation of innovative, surgery-centred, multi-modal cancer treatments for advanced or metastatic disease, emphasizing affordability, patient engagement, and interdisciplinary collaboration.
Key Information: Proposals must be academic investigator-initiated clinical trials with multidisciplinary consortia and cost-effectiveness analysis.